Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasper Stevens

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Diabetes, Obesity & Metabolism|August 16, 2019
Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatinMarjolein Y A M Kroonen, Jasper Stevens, Dick de Zeeuw, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 6, 2020
Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modelingMichiel J van Esdonk, Jacobus Burggraaf, Marion Dehez, et al.
Pharmaceutical Research|May 20, 2009
A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugsJasper Stevens, Ernst Suidgeest, Piet Hein van der Graaf, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 21, 2026
OpenPMX Software for Nonlinear Mixed-Effect Models in Pharmacometrics: Precision Compared With NONMEM First-Order Conditional EstimationDouglas J Eleveld, Jeroen V Koomen, Jasper Stevens, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2026
Indexing for Body Surface Area when Assessing Kidney FunctionAbdulfataah A A Mohamed, Marco van Londen, Jasper Stevens, et al.
British Journal of Clinical Pharmacology|December 1, 2015
Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge testsZheng Guan, Linda E Klumpers, Olubukayo-Opeyemi Oyetayo, et al.
Peerj|November 29, 2023
Gait and dynamic pedobarographic analyses in hallux rigidus patients treated with Keller's arthroplasty, arthrodesis or cheilectomy 22 years after surgeryRobin de Bot, Jasper Stevens, Thijs Smeets, et al.
Frontiers in Pharmacology|May 17, 2021
A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in EuropeJeroen V Koomen, Jasper Stevens, Margje H Monster-Simons, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 26, 2018
Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy SubjectsMichiel J van Esdonk, Ian Lindeman, Pieter Okkerse, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 10, 2011
Systemic and direct nose-to-brain transport pharmacokinetic model for remoxipride after intravenous and intranasal administrationJasper Stevens, Bart A Ploeger, Piet H van der Graaf, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Diabetes, Obesity & Metabolism|August 16, 2019
Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatinMarjolein Y A M Kroonen, Jasper Stevens, Dick de Zeeuw, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 6, 2020
Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modelingMichiel J van Esdonk, Jacobus Burggraaf, Marion Dehez, et al.
Pharmaceutical Research|May 20, 2009
A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugsJasper Stevens, Ernst Suidgeest, Piet Hein van der Graaf, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 21, 2026
OpenPMX Software for Nonlinear Mixed-Effect Models in Pharmacometrics: Precision Compared With NONMEM First-Order Conditional EstimationDouglas J Eleveld, Jeroen V Koomen, Jasper Stevens, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2026
Indexing for Body Surface Area when Assessing Kidney FunctionAbdulfataah A A Mohamed, Marco van Londen, Jasper Stevens, et al.
British Journal of Clinical Pharmacology|December 1, 2015
Pharmacokinetic/pharmaco-dynamic modelling and simulation of the effects of different cannabinoid receptor type 1 antagonists on Δ(9)-tetrahydrocannabinol challenge testsZheng Guan, Linda E Klumpers, Olubukayo-Opeyemi Oyetayo, et al.
Peerj|November 29, 2023
Gait and dynamic pedobarographic analyses in hallux rigidus patients treated with Keller's arthroplasty, arthrodesis or cheilectomy 22 years after surgeryRobin de Bot, Jasper Stevens, Thijs Smeets, et al.
Frontiers in Pharmacology|May 17, 2021
A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in EuropeJeroen V Koomen, Jasper Stevens, Margje H Monster-Simons, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 26, 2018
Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy SubjectsMichiel J van Esdonk, Ian Lindeman, Pieter Okkerse, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 10, 2011
Systemic and direct nose-to-brain transport pharmacokinetic model for remoxipride after intravenous and intranasal administrationJasper Stevens, Bart A Ploeger, Piet H van der Graaf, et al.
Pageof 8